Abstract
Objective
We investigated the prevalence of the human Papillomavirus (HPV) and its genotypes in women with normal cervical cytology in the state of Paraná, Brazil, and also epidemiological characteristics.
Methods
The enrolled patients were seen at six primary health-care units in Paiçandú City, Paraná. Through polymerase chain reaction (PCR) and PCR–RFLP (restriction fragment length polymorphism) techniques, 40 HPV genotypes were found, including 15 high risk, 3 undetermined risk and 22 low risk. Socio-demographic characteristics and sexual behavior were also recorded by interviews based on a structured questionnaire completed at the time of enrollment.
Results
Among 418 patients examined, HPV was detected in 6.7 %, mainly in women aged <25 years. The overall prevalence of high-risk, low-risk and undetermined-risk HPV types was 42.9, 45.7, and 11.7 %, respectively. HPV-16 was the most common type detected (14.3 %), followed by types 66 (11.4 %) and 31 and 70 (8.6 % each). Detection of HPV DNA was positively associated with the number of sexual partners within the previous 12 months (p < 0.031; OR = 5.4; CI = 0.98–29.8).
Conclusion
When considering the lack of studies in Paraná on women with normal cytology, the results of this study will improve estimates of HPV DNA populations, and provide baseline values against which the impact of vaccination can be assessed in the future.
Similar content being viewed by others
References
Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917
Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE (2011) Human Papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 103:1–16
National Cancer Institute (2009) Estimate 2010: cancer incidence in Brazil, Rio de Janeiro, 2009. http://www.inca.gov.br/estimativa/2010/estimativa2009.pdf
Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK et al (1999) Relation of Human Papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354:20–25
Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S (2010) Cervical Human Papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202:1789–1799
de Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz N et al (2007) Worldwide prevalence and genotype distribution of cervical human Papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453–459
Forinash AB, Yancey AM, Pitlick JM, Myles TD (2011) Safety of the HPV bivalent and quadrivalent vaccines during pregnancy. Ann Pharmacother 45:258–262
European Cervical Cancer Association (2009) HPV vaccination across Europe. http://www.ecca.info/fileadmin/user_upload/HPV_Vaccination/ECCA_HPV_Vaccination_April_2009.pdf
Merck. Broad Spectrum HPV (Human Papillomavirus) vaccine study in 16-to 26-year-old women (V503-001). http://clinicaltrials.gov/ct2/show/NCT00543543. Accessed 20 March 2011
Solomon D, Nayar R (2005) Bethesda system for cervical–vaginal cytology. Revinter, Rio de Janeiro, pp 67–87
Qu W, Jiang G, Cruz Y, Chang CJ, Ho GYF, Klein R et al (1997) PCR detection of human Papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35:1304–1310
Santiago E, Camacho L, Junquera ML, Vásquez F (2006) Full HPV typing by a single restriction enzyme. J Clin Virol 37:38–46
Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991–998
Lorenzato F, Ho L, Terry G, Singer A, Santos LC, Lucena BR et al (2000) The use of women papillomavirus in detection of cervical neoplasia in Recife (Brazil). Int J Gynecol Cancer 10:143–150
Krambeck WM, Candidé RM, Dalmaco EM, de Cordova CM (2008) HPV detection and genotyping as an earlier approach in cervical cancer screening of the female genital tract. Clin Exp Obstet Gynecol 35:175–178
Lippeman SA, Sucupira MCA, Jones HE, Luppi CG, Palefsky J, Van de Wiigert JHHM, Oliveira RLS, Diaz RS (2010) Frequence, distribution and correlates of endocervical human papillomavirus types in Brazilian women. Int J STD AIDS 21:105–109
Rosa MI, Fachel JMG, Rosa DD, Medeiros LR, Igansi CN, Bozzetti MC (2008) Persistence and clearance of human papillomavirus infection: a prospective cohort study. Am J Obstet Gynecol 99:1–7
Fernandes JV, Meissner RV, Carvalho MGF, Fernandes TAAM, Azevedo PRM, Villa L (2009) Prevalence of HPV infection by cervical cytologic status in Brazil. Int J Gynaecol Obstet 105:21–24
Rossi PG, Bisanzi S, Paganini I, Di Lasi A, Angeloni C, Scalisi A et al (2010) Frequency of HPV high and low risk types in cervical samples from the Italian general population: a population based study. BMC Infect Dis 10:1–13
Uusküla A, Kals M, Kosenkranius L, McNutt LA, DeHovitz (2010) Population-based type-specific frequency of high-risk human papillomavirus infection in Estonia. BMC Infect Dis 10:1–8
Gontijo RC, Derchain SF, Roteli-Martins C, Bragança JF, Sarian LO, Morais SS et al (2007) Human Papillomavirus (HPV) infections as risk factors for cytological and histological abnormalities in baseline PAP smear-negative women followed-up for 2 years in the LAMS study. Eur J Obstet Gynecol Reprod Biol 133:239–246
de Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz M et al (2003) Cervical human Papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 30:788–793
Eluf-Neto J, Nascimento CM (2001) Cervical cancer in Latin America. Semin Oncol 28:188–197
Kjær SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T (2008) Population-based frequency, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 123:1864–1870
Molano M, Posso H, Weiderpass E, van den Brule AJC, Ronderos M, Franceschi S et al (2002) Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 87:324–333
Stamataki P, Papazafiroupoulou A, Elefsiniostis I, Giannakopoulous M, Brokalaki H, Apostolopoulou E et al (2010) Prevalence of HPV infection among Greek women attending a gynecological outpatient clinic. BMC Infect Dis 10:1–6
Confortini M, Carozzi F, Zappa M, Ventura L, Iossa A, Cariagge P et al (2010) Human Papillomavirus infection and risk factors in a cohort of Tuscan woman aged 18–24: results at recruitment. BMC Infect Dis 10:1–11
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
da Silva, M.C., Martins, H.P.R., de Souza, J.L. et al. Prevalence of HPV infection and genotypes in women with normal cervical cytology in the state of Paraná, Brazil. Arch Gynecol Obstet 286, 1015–1022 (2012). https://doi.org/10.1007/s00404-012-2399-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-012-2399-y